302 related articles for article (PubMed ID: 28201779)
21. Glioblastoma: pathology, molecular mechanisms and markers.
Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
[TBL] [Abstract][Full Text] [Related]
22. Pediatric glioblastomas: a histopathological and molecular genetic study.
Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
[TBL] [Abstract][Full Text] [Related]
23. Evolving Molecular Genetics of Glioblastoma.
Li QJ; Cai JQ; Liu CY
Chin Med J (Engl); 2016 Feb; 129(4):464-71. PubMed ID: 26879021
[TBL] [Abstract][Full Text] [Related]
24. Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.
Cantero D; Rodríguez de Lope Á; Moreno de la Presa R; Sepúlveda JM; Borrás JM; Castresana JS; D'Haene N; García JF; Salmon I; Mollejo M; Rey JA; Hernández-Laín A; Meléndez B
J Neuropathol Exp Neurol; 2018 Aug; 77(8):710-716. PubMed ID: 30010995
[TBL] [Abstract][Full Text] [Related]
25. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
26. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
[TBL] [Abstract][Full Text] [Related]
27. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
[TBL] [Abstract][Full Text] [Related]
28. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathologic diagnosis of epidermal growth factor receptor.
Maire CL; Ligon KL
Neuro Oncol; 2014 Oct; 16 Suppl 8(Suppl 8):viii1-6. PubMed ID: 25342599
[TBL] [Abstract][Full Text] [Related]
30. Congenital glioblastoma: a clinicopathologic and genetic analysis.
Brat DJ; Shehata BM; Castellano-Sanchez AA; Hawkins C; Yost RB; Greco C; Mazewski C; Janss A; Ohgaki H; Perry A
Brain Pathol; 2007 Jul; 17(3):276-81. PubMed ID: 17465990
[TBL] [Abstract][Full Text] [Related]
31. Clonal analysis in glioblastoma with epithelial differentiation.
Mueller W; Lass U; Herms J; Kuchelmeister K; Bergmann M; von Deimling A
Brain Pathol; 2001 Jan; 11(1):39-43. PubMed ID: 11145202
[TBL] [Abstract][Full Text] [Related]
32. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetic analysis of giant cell glioblastomas.
Meyer-Puttlitz B; Hayashi Y; Waha A; Rollbrocker B; Boström J; Wiestler OD; Louis DN; Reifenberger G; von Deimling A
Am J Pathol; 1997 Sep; 151(3):853-7. PubMed ID: 9284834
[TBL] [Abstract][Full Text] [Related]
34. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma.
Mahlokozera T; Vellimana AK; Li T; Mao DD; Zohny ZS; Kim DH; Tran DD; Marcus DS; Fouke SJ; Campian JL; Dunn GP; Miller CA; Kim AH
Neuro Oncol; 2018 Mar; 20(4):472-483. PubMed ID: 29244145
[TBL] [Abstract][Full Text] [Related]
35. The role of TP53 gain-of-function mutation in multifocal glioblastoma.
Olafson LR; Gunawardena M; Nixdorf S; McDonald KL; Rapkins RW
J Neurooncol; 2020 Mar; 147(1):37-47. PubMed ID: 32002804
[TBL] [Abstract][Full Text] [Related]
36. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
37. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma.
Matsumura N; Nakajima N; Yamazaki T; Nagano T; Kagoshima K; Nobusawa S; Ikota H; Yokoo H
Neuropathology; 2017 Feb; 37(1):58-63. PubMed ID: 27302309
[TBL] [Abstract][Full Text] [Related]
38. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
Kunkle B; Yoo C; Roy D
Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
[TBL] [Abstract][Full Text] [Related]
39. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
Tang C; Guo J; Chen H; Yao CJ; Zhuang DX; Wang Y; Tang WJ; Ren G; Yao Y; Wu JS; Mao Y; Zhou LF
Int J Clin Exp Pathol; 2015; 8(5):5327-35. PubMed ID: 26191234
[TBL] [Abstract][Full Text] [Related]
40. EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.
Francis JM; Zhang CZ; Maire CL; Jung J; Manzo VE; Adalsteinsson VA; Homer H; Haidar S; Blumenstiel B; Pedamallu CS; Ligon AH; Love JC; Meyerson M; Ligon KL
Cancer Discov; 2014 Aug; 4(8):956-71. PubMed ID: 24893890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
